Download presentation
Presentation is loading. Please wait.
Published byHoward Brooks Modified over 6 years ago
1
Survival Benefit of Lung Transplantation for Chronic Obstructive Pulmonary Disease in Sweden
Hanan A. Tanash, PhD, Gerdt C. Riise, PhD, Magnus P. Ekström, PhD, Lennart Hansson, PhD, Eeva Piitulainen, PhD The Annals of Thoracic Surgery Volume 98, Issue 6, Pages (December 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Kaplan-Meier analysis of mortality after lung transplantation in 128 recipients with severe alpha-1-antitrypsin deficiency (AATD [dashed line]) and 214 non-AATD recipients (dashed-dotted line) with usual chronic obstructive pulmonary disease. This analysis showed a significant difference in survival time between AATD recipients and non-AATD recipients, with median survival times of 12 years and 6 years, respectively (p = 0.000). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Kaplan-Meier analysis of mortality in 243 patients who had received single lung transplants (LT [broken line]) and 99 patients who had received bilateral LT (solid line). The median survival time for bilateral LT recipients was 12 years compared to 8 years for single LT recipients (p = 0.30). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.